【🇯🇵JAPAN】Nafamostat/Camostat【COVID19】
Let me share one of the #COVID19 solutions in 🇯🇵Japan, using existing Japanese 【pancreatitis drug】, Nafamostat, which is expected to 【prevent】 the transmission of the #NovelCoronavirus infection.
(continue)
【The University of Tokyo (March 18, 2020)】
★Identification of an 【existing】 🇯🇵Japanese pancreatitis drug, Nafamostat, which is expected to 【PREVENT】 the transmission of the #NovelCoronavirus infection (#COVID19 ).
(continue)
★Both Nafamostat and Camostat were developed in #Japan as treatments for pancreatitis and some other diseases.
★These drugs have been prescribed in Japan for many years and have adequate clinical data with regard to safety.
(continue)
★Nafamostat mesylate (brand name: #Fusan), which is the drug used to treat acute pancreatitis, may effectively block the requisite viral entry process the new coronavirus (SARS-CoV-2) uses to spread and cause disease (COVID-19).
(continue)
★According to the new research, Nafamostat can 【PREVENT】the fusion of the envelope of the virus with host cell surface membranes, the first step in infection with the causative virus SARS-CoV-2.
Details...↓↓
u-tokyo.ac.jp/focus/en/artic…